References
- Camp KM, Parisi MA, Acosta PB, et al. Phenylketonuria Scientific Review Conference: state of the science and future research needs. Mol Genet Metab 2014;112:87–122.
- Maillot F, Cook P, Lilburn M, et al. A practical approach to maternal phenylketonuria management. J Inherit Metab Dis 2007;30:198–201.
- Vockley J, Andersson HC, Antshel KM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 2014;16:188–200.
- Koch R, Moseley K, Guttler F. Tetrahydrobiopterin and maternal PKU. Mol Genet Metab 2005;86 Suppl 1:S139–41.
- Aldamiz-Echevarria L, Couce ML, et al. A new case of maternal phenylketonuria treated with sapropterin dihydrochloride (6R-BH4). Gynecol Endocrinol 2014;30:691–3.
- Feillet F, Muntau AC, Debray FG, et al. Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases. J Inherit Metab Dis 2014;37:753–62.
- Grange DK, Hillman RE, Burton BK, et al. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry. Mol Genet Metab 2014;112:9–16.
- Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet 2010;376:717–29.
- Prick BW, Hop WC, Duvekot JJ. Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies. Am J Clin Nutr 2012;95:374–82.
- Heitzer T, Krohn K, Albers S, et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000;43:1435–8.
- Herrero MB, de Lamirande E, Gagnon C. Nitric oxide is a signaling molecule in spermatozoa. Curr Pharm Des 2003;9:419–25.
- Teissier R, Nowak E, Assoun M, et al. Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation. J Inherit Metab Dis 2012;35:993–9.